Pretty gutsy of them... Meet AMILI! This Singapore-based biotech focuses on gut microbiomes (aka, the teeny tiny microorganisms in your gut) to improve human health. Now, they've just raised a $10.5M Series A.

• More than just nerdy stuff. Better gut health can mean a better immune system, improved heart health, brain health, metabolism and sleep.
  

Who cashed in? Vulcan Capital led the round. Pruksa Group, TVM Capital Healthcare, Emtek Group, Capital Code, SEEDS Capital, Pureland Group, Blue7 and GK Goh also joined in.

• The round brought in experts with expertise in biotech, healthcare and foodtech to help AMLI expand into microbiome diagnostics and interventions like functional food and clinical therapeutics.
  

🔬 What they do

D2C health brand. Their gut health brand, BIO & ME, has gut health tests and probiotics just for you.

• Test the millions of bacteria in your gut to understand wellness indicators (from the brain to metabolism), get dietary recommendations, know health and disease insights and more.
  

Analytics engine. This allows them to develop diagnostics tests, microbiome-modifying tools and predictive algorithms.

Food partners. They offer end-to-end gut microbiome services from study design and collection to analysis. This way, they help unlock food and food ingredients' effects on the microbiome and human health.

• They'll validate health effects, co-develop the product and do R&D like create recipes and formulas.
  

Transplants. They also help make transplants of microbiome material possible to cure patients suffering from infections.

• They're SEA's first microbiome bank for Faecal Microbiota Transplants (FMT)

🧬 Research at the heart

Zooming out. While the gut health field has advanced, having a local firm like AMILI closes the major gap with the lack of gut health research, samples and data properly representing the Asian population.

💰 What's with the $$$?

They plan to expand across SEA and the rest of Asia. Plus, they'll be developing their proprietary microbiome analytics engine and bringing their D2C brand to new markets